Media Coverage header image

Media Coverage

Advanced Search
  • 10192021
    Clinical Lab Products

    Quest Diagnostics, a diagnostics services provider in oncology and genetics, has announced that it will provide clinical laboratory testing using the Ki-67 IHC MIB-1 pharmDx (Dako Omnis) immunohistochemistry companion diagnostic.

  • 10152021
    Forbes

    The New York City-based startup recently launched a new partnership with Quest Diagnostics and brought on Devon Kennard, an American football linebacker for the Arizona Cardinals of the National Football League (NFL), as an investor in the company.

  • 10122021
    ROI-NJ

    Quest Diagnostics Inc. has completed the consolidations of its Northeast regional operations into its new, 250,000-square-foot facility at ON3 in Clifton, it announced Tuesday. The Secaucus-based diagnostic testing company said in a news release that the lab will serve more than 40 million people per year in seven states, increasing productivity and capacity. It is capable of more than 300,000 tests per day thanks to extensive automation, the company noted.

  • 10122021
    Bloomberg Radio

    Steve Rusckowski, Chairman and CEO of Quest Diagnostics, discusses opening a highly automated diagnostic testing facility in New Jersey.

  • 10122021
    CNBC

    Meg Tirrell joins The Exchange with Quest Diagnostics CEO Steve Rusckowski to discuss the future of Covid testing. As the flu and cold seasons return, Rusckowski says, he expects more people will turn up to Covid testing when they present symptoms that are similar to those of Covid, the flu and the common cold.

Show 5102550100 per page